Belupo is the leading company in Croatia in selling of medicine concerning cardiovascular system and medicine with the impact to the skin, and second large pharmaceutical company in Croatia.

The main Belupo activity, who at the end of 2006. was celebrating his 35rd anniversary, is the production and selling of pharmaceutical preparations and cosmetic products, and is organised as  joint-stock company with HQ in Koprivnica.

With it’s organisation and manner of work the company is adapting to the recent business transactions in domestic and foreign market.

By the continuous work-out of strategic development and export activities, continuous building of security system and the quality control, permanent expert improvement of it’s employees and investing in the capacities and programmes, Belupo is creating enviable position of one of the leading drug producers in middle and south-east Europe.

Last year the primary medical care in Australia announced that smokers would be taken off from the operation lists in order to reduce costs. In the recently published British Medical Journalu two experts have stated their opinion. To refuse to operate a patient...